Specialized Self-Emulsifying Cannabidiol Formulations for Niche Applications

Publication ID: 24-11857678_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Self-Emulsifying Cannabidiol Formulations for Niche Applications,” Published Technical Disclosure No. 24-11857678_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857678_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,678.

Summary of the Inventive Concept

This inventive concept adapts self-emulsifying cannabidiol formulations for specific, narrow markets or unique operational environments, such as treating opioid addiction, chronic pain in chemotherapy patients, veterinary use, anxiety disorders in children, and sleep disorders in the elderly.

Background and Problem Solved

The original patent disclosed self-emulsifying cannabidiol compositions for general therapeutic applications. However, certain niche markets or operational environments require specialized formulations that address specific challenges, such as extreme temperatures, pediatric or veterinary use, or specific disease indications. The present inventive concept addresses these limitations by providing tailored formulations for these unique applications.

Detailed Description of the Inventive Concept

The new inventive concept comprises self-emulsifying cannabidiol formulations adapted for specific niche applications. Claim 1 addresses opioid addiction by incorporating an opioid receptor antagonist. Claim 2 targets chronic pain in chemotherapy patients by formulating the composition to withstand extreme temperatures. Claim 3 is designed for veterinary use, incorporating a flavoring agent. Claim 4 addresses anxiety disorders in children, utilizing a pediatric-friendly excipient. Claim 5 focuses on treating sleep disorders in the elderly, incorporating a sleep-promoting agent. These specialized formulations ensure optimal performance and efficacy in their respective applications.

Novelty and Inventive Step

The novelty of this inventive concept lies in the adaptation of self-emulsifying cannabidiol formulations for specific, narrow markets or unique operational environments. The inventive step resides in the selection of specific components, such as opioid receptor antagonists, flavoring agents, pediatric-friendly excipients, or sleep-promoting agents, which enable the formulations to address the particular challenges of each niche application.

Alternative Embodiments and Variations

Alternative embodiments of this inventive concept could include formulations adapted for disaster relief, high-security needs, or extreme weather conditions. Variations could involve different surfactants, oils, or antioxidants to optimize performance in specific applications.

Potential Commercial Applications and Market

This inventive concept has significant commercial potential in various industries, including pharmaceuticals, veterinary medicine, and nutraceuticals. The specialized formulations can be marketed to address specific therapeutic needs, such as opioid addiction, chronic pain, anxiety disorders, or sleep disorders, in various patient populations.

CPC Classifications

SectionClassGroup
A A61 A61K9/107
A A61 A61K9/4808
A A61 A61K9/4825
A A61 A61K31/05
A A61 A61K47/10
A A61 A61K47/14
A A61 A61K47/22

Original Patent Information

Patent NumberUS 11,857,678
TitleSelf-emulsifying cannabidiol formulations
Assignee(s)Benuvia Operations, LLC